Cargando…
Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol
The COVID-19 pandemic, the growth of smartphones, and the internet have driven the use of technology for monitoring TB patients. Innovation in management of TB patients is needed to improve treatment outcomes. The study was conducted to obtain a predictive model of medication safety and solution mod...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451058/ https://www.ncbi.nlm.nih.gov/pubmed/36070321 http://dx.doi.org/10.1371/journal.pone.0272616 |
_version_ | 1784784655307767808 |
---|---|
author | Wijayanti, Erlina Bachtiar, Adang Achadi, Anhari Rachmawati, Ummi Azizah Sjaaf, Amal Chalik Eryando, Tris Besral, Trihono, Siregar, Kemal N. Vidiawati, Dhanasari |
author_facet | Wijayanti, Erlina Bachtiar, Adang Achadi, Anhari Rachmawati, Ummi Azizah Sjaaf, Amal Chalik Eryando, Tris Besral, Trihono, Siregar, Kemal N. Vidiawati, Dhanasari |
author_sort | Wijayanti, Erlina |
collection | PubMed |
description | The COVID-19 pandemic, the growth of smartphones, and the internet have driven the use of technology for monitoring TB patients. Innovation in management of TB patients is needed to improve treatment outcomes. The study was conducted to obtain a predictive model of medication safety and solution model for at-risk patients, and to improve medication safety through mobile applications. The research was conducted in 4 stages, namely qualitative, quantitative (cross-sectional), qualitative, and quantitative (quasi-experimental, post-test group control design). Data were taken at the Public Health Center in Jakarta, Indonesia. Samples were taken by cluster random sampling. For quantitative research, 2(nd) phase (n = 114) and 4(th) phase (n = 96) were analyzed using logistic regression. This study analyzed predictors of medication safety to assist in monitoring patients undergoing treatment. At-risk patients were educated using an algorithm programmed in the application. |
format | Online Article Text |
id | pubmed-9451058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-94510582022-09-08 Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol Wijayanti, Erlina Bachtiar, Adang Achadi, Anhari Rachmawati, Ummi Azizah Sjaaf, Amal Chalik Eryando, Tris Besral, Trihono, Siregar, Kemal N. Vidiawati, Dhanasari PLoS One Study Protocol The COVID-19 pandemic, the growth of smartphones, and the internet have driven the use of technology for monitoring TB patients. Innovation in management of TB patients is needed to improve treatment outcomes. The study was conducted to obtain a predictive model of medication safety and solution model for at-risk patients, and to improve medication safety through mobile applications. The research was conducted in 4 stages, namely qualitative, quantitative (cross-sectional), qualitative, and quantitative (quasi-experimental, post-test group control design). Data were taken at the Public Health Center in Jakarta, Indonesia. Samples were taken by cluster random sampling. For quantitative research, 2(nd) phase (n = 114) and 4(th) phase (n = 96) were analyzed using logistic regression. This study analyzed predictors of medication safety to assist in monitoring patients undergoing treatment. At-risk patients were educated using an algorithm programmed in the application. Public Library of Science 2022-09-07 /pmc/articles/PMC9451058/ /pubmed/36070321 http://dx.doi.org/10.1371/journal.pone.0272616 Text en © 2022 Wijayanti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Study Protocol Wijayanti, Erlina Bachtiar, Adang Achadi, Anhari Rachmawati, Ummi Azizah Sjaaf, Amal Chalik Eryando, Tris Besral, Trihono, Siregar, Kemal N. Vidiawati, Dhanasari Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol |
title | Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol |
title_full | Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol |
title_fullStr | Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol |
title_full_unstemmed | Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol |
title_short | Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol |
title_sort | mobile application development for improving medication safety in tuberculosis patients: a quasi-experimental study protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451058/ https://www.ncbi.nlm.nih.gov/pubmed/36070321 http://dx.doi.org/10.1371/journal.pone.0272616 |
work_keys_str_mv | AT wijayantierlina mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT bachtiaradang mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT achadianhari mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT rachmawatiummiazizah mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT sjaafamalchalik mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT eryandotris mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT besral mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT trihono mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT siregarkemaln mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol AT vidiawatidhanasari mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol |